18.02.2019 • NewsElaine BurridgeMitsui

Mitsui, ISK Take Stakes in Brazil’s Ourofino

Mitsui, ISK Take Stakes in Brazil’s Ourofino (c) Ourofino
Mitsui, ISK Take Stakes in Brazil’s Ourofino (c) Ourofino

Japanese companies Mitsui & Co. and Ishihara Sangyo Kaisha (ISK) have signed a binding agreement to jointly acquire a 25% stake in Brazilian agrochemical company, Ouro Fino Quimica. Mitsui will take a 20% share of Ourofino, with ISK taking 5%.

Completion of the transaction is subject to customary conditions and regulatory approval. The companies have not revealed financial details.

Located in Uberaba, Minas Gerais, Ourofino manufactures a range of agrochemicals, including fungicides, herbicides and insecticides.

Mitsui said it intends with ISK to contribute to expanding Ourofino’s business in Brazil, which is the world’s largest market for crop protection products, accounting for about 20% of global demand. Ourofino will benefit from access to Mitsui’s assets around the world and will include ISK’s products, which include herbicides, fungicides, insecticides and nematicides, into its portfolio.

As part of its medium-term management plan, Mitsui has identified nutrition and agriculture as one of its key new growth areas. The Tokyo-headquartered group distributes agrochemicals and agricultural supplies in Europe through wholly owned subsidiary Mitsui AgriScience International Europe and in the US through its fully owned biopesticides division Certis USA.

Company

Logo:

Mitsui Chemicals Europe GmbH

Oststr. 34
40211 Düsseldorf
Germany

Company contact







Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read